Sign Up to like & get
recommendations!
0
Published in 2020 at "Neuro-oncology"
DOI: 10.1093/neuonc/noaa260
Abstract: BACKGROUND Radiotherapy may synergize with programmed death 1 (PD-1)/PD-1 ligand (PD-L1) blockade. The purpose of this study was to determine the recommended Phase II dose, safety/tolerability, and preliminary efficacy of combining pembrolizumab, an anti-PD-1 monoclonal…
read more here.
Keywords:
bevacizumab;
stereotactic irradiation;
hypofractionated stereotactic;
bevacizumab patients ... See more keywords